Yuanfang Li

Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Author Correction: Neuroimmune cardiovascular interfaces control atherosclerosis.

Author Correction: Neuroimmune cardiovascular interfaces control atherosclerosis.

Journal: Nature
Published: December 17, 2025

Microglia activation by derepression of endogenous retroviruses drives inflammation and cellular senescence.

Microglia activation by derepression of endogenous retroviruses drives inflammation and cellular senescence.

Journal: Nature neuroscience
Published: July 01, 2024

Satb1 directs the differentiation of TH17 cells through suppression of IL-2 expression.

Satb1 directs the differentiation of TH17 cells through suppression of IL-2 expression.

Journal: Cell reports
Published: January 16, 2024

From Planning Stage Towards FAIR Data: A Practical Metadatasheet For Biomedical Scientists.

From Planning Stage Towards FAIR Data: A Practical Metadatasheet For Biomedical Scientists.

Journal: Scientific data
Published: December 07, 2023

Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis.

Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis.

Journal: Nature cardiovascular research
Published: August 25, 2023

Chromatin accessibility profiling of targeted cell populations with laser capture microdissection coupled to ATAC-seq.

Chromatin accessibility profiling of targeted cell populations with laser capture microdissection coupled to ATAC-seq.

Journal: Cell reports methods
Published: March 27, 2023

The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell Function.

The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell Function.

Journal: Circulation research
Published: September 14, 2022

The C1q-ApoE complex: A new hallmark pathology of viral hepatitis and nonalcoholic fatty liver disease.

The C1q-ApoE complex: A new hallmark pathology of viral hepatitis and nonalcoholic fatty liver disease.

Journal: Frontiers in immunology
Published: June 16, 2022

Tissue Clearing Approaches in Atherosclerosis.

Tissue Clearing Approaches in Atherosclerosis.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 03, 2022

Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb.

Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb.

Journal: Theranostics
Published: July 03, 2020

Neuroimmune cardiovascular interfaces control atherosclerosis.

Neuroimmune cardiovascular interfaces control atherosclerosis.

Journal: Nature
Published: February 11, 2020

Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1q.

Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1q.

Journal: Nature medicine
Published: February 06, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026